The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Drug Eluting Balloons Catheters Global Market Report 2024, the drug eluting balloons catheters market is expected to show significant growth in the forecast period.

Market Growth Trajectory

• Rapid growth: from $1.23 billion in 2023 to $1.43 billion in 2024, with a CAGR of 16.3%.
• Future forecast: Expected to reach $2.35 billion by 2028, growing at a CAGR of 13.2%.

Drivers of Growth

• Expanding prevalence of cardiovascular and peripheral diseases.
• Introduction of newest-generation products advancing coronary artery disease treatment.

Expanding Prevalence Of Cardiovascular And Peripheral Diseases

• Rising cases of cardiovascular diseases and peripheral artery diseases propel market growth.
• Drug-eluting balloon catheters offer effective treatment options for coronary artery disease and peripheral artery disease.
• Major market players include Abbott Laboratories, Medtronic PLC, and Becton Dickinson and Company.

Introducing Newest-Generation Products For Advancing Coronary Artery Disease Treatment

• Market leaders focus on innovation to enhance treatment effectiveness.
• Medtronic PLC launched Prevail DCB in Europe, employing advanced technologies for coronary artery disease treatment.
• Recent acquisitions, like Translumina Therapeutics acquiring Blue Medical Devices, contribute to market expansion.

View More On The Drug Eluting Balloons Catheters Market Report 2024 – https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Market Segmentation

• Products: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
• Drugs: Paclitaxel, Sirolimus, Others
• Raw Materials: Nylon, Polyurethane, Others
• End-Users: Hospitals and Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Regional Insights

• North America led the market in 2023.
• Asia-Pacific expected to witness the fastest growth in the forecast period.

Conclusion

The drug eluting balloon catheters market is experiencing robust growth driven by the increasing prevalence of cardiovascular and peripheral diseases. With advancements in treatment technologies and expanding market segments, the future of drug eluting balloon catheters looks promising, offering significant growth opportunities for market players globally.

Request A Sample Of The Global Drug Eluting Balloons Catheters Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13429&type=smp